Olopatadine Hydrochloride

CHEMBL1719 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
373.9 g/mol
LogP
Phase
4

A hydrochloride salt form of olopatadine with the same therapeutic properties. An antihistamine and mast cell stabilizer treating eye allergies, nasal allergies, and atopic dermatitis.

आणविक भार

373.9000 g/mol

TPSA

49.80 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl

InChI

InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;

Molecular Formula

C21H24ClNO3

HBD / HBA

2 / 4

घूर्णनीय बंधन

5

भारी परमाणु

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

A hydrochloride salt form of olopatadine with the same therapeutic properties. An antihistamine and mast cell stabilizer treating eye allergies, nasal allergies, and atopic dermatitis.

Yes, Olopatadine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1719. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5282402. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.